DuPont/Merck Cozaar Profit-Sharing Trigger May Take Effect In 2000
Executive Summary
A 50/50 profit-sharing clause in Merck's license to DuPont's angiotensin II antihypertensives could be an important source of growth for DuPont's reacquired pharmaceutical business by the turn of the century.